Page last updated: 2024-12-10

quercitrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5280459
CHEMBL ID82242
CHEBI ID17558
SCHEMBL ID147092
MeSH IDM0059611

Synonyms (114)

Synonym
AC-20295
BIDD:PXR0076
brn 0068135
quercetin 3-o-alpha-l-rhamnoside
mannopyranoside, quercetin-3 6-deoxy-, alpha-l-
quercetin, 3-(6-deoxy-alpha-l-mannopyranoside)
3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-benzopyran-4-one
ai3-36095
flavone, 3,3',4',5,7-pentahydroxy-, 3-rhamnoside
ci 75720
hsdb 4339
flavone, 3,3',4',5,7-pentahydroxy-, 3-(6-deoxy-alpha-l-mannopyranoside)
4h-1-benzopyran-4-one, 3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
3-((6-deoxy-alpha-l-mannopyranosyl)-oxy)-2-(3,4-dihydr oxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
quercetrin-3-o-rham
einecs 208-322-5
nci-c60102
CHEMBL82242 ,
2y8906lc5p ,
5-18-05-00514 (beilstein handbook reference)
unii-2y8906lc5p
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-deoxy-alpha-l-mannopyranoside
quercitronic acid
3,3',4',5,7-pentahydroxyflavone-3-l-rhamnoside
luteolin 6-deoxy-alpha-l-mannopyranoside
3-((6-deoxy-alpha-l-mannopyranosyl)-oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
CHEBI:17558 ,
quercetin 3-o-alpha-rhamnopyranoside
SMP1_000253
ACON1_000189
quercetin 3-o-rhamnoside
rhamnosyl-3-quercitin
c.i. 75720
quercetin-3-o-rhamnoside
rhamnoside, quercetin-3
quercetin-3-l-rhamnoside
nsc9221 ,
quercetin 3-rhamnoside
usaf cf-2
quercimelin
quercetrin
quercetin 3-o-.alpha.-l-rhamnoside
quercetin 3-o-l-rhamnoside
quercitroside
quercetin-3-rhamnoside
quercitin-3-rhamnoside
nsc-9221
MEGXP0_000185
4h-1-benzopyran-4-one, 3-((6-deoxy-.alpha.-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
thujin
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-chromen-4-one
quercetin 3-l-rhamnoside
C01750
quercitrin ,
quercetin 3-o-alpha-l-rhamnopyranoside
522-12-3
AKOS000278033
BRD-K98601533-001-01-7
MLS002472998
smr001397103
quercetin 3-o-rhamnopyranoside
quercetin-3-o-alpha-rhamnoside
quercetin 3-rhamnopyranoside
bdbm50056315
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one
HMS2219D24
cid_5280459
bdbm84978
S3824
4GUE
QCT ,
SCHEMBL147092
3,3',4',5,7-pentahydroxyflavone 3-l-rhamnoside
quercetin-3-o-.alpha.-rhamnoside
quercetin 3-o-.alpha.-rhamnopyranoside
3-o-rhamnosylquercetin
wa 17779
quercetin 3-o-.alpha.-l-rhamnopyranoside
quercitrin [hsdb]
5,7,3',4'-tetrahydroxyflavonol 3-o-rhamnoside
quercitrin (quercetin-3-o- rhamnoside) (constituent of ginkgo) [dsc]
3-o-.alpha.-l-rhamnopyranosylquercetin
3-((6-deoxy-.alpha.-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one
quercitrin [mi]
AC-34266
Q-100588
Q-100945
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4h-chromen-3-yl 6-deoxy-.alpha.-l-mannopyranoside
OXGUCUVFOIWWQJ-HQBVPOQASA-N
4h-1-benzopyran-4-one, 3-[(6-deoxy-.alpha.-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
mfcd00016932
HY-N0418
CS-5408
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-4h-chromen-4-one
DTXSID50200230 ,
3-rhamnosyl quercetin
quercitrin, primary pharmaceutical reference standard
flavone, 3,3',4',5, 7-pentahydroxy-, 3-rhamnoside
3-o-a-l-rhamnopyranosyloxy-3',4',5,7-tetrahydroxyflavone
((2s,3r,4r,5r,6s)-3,4,
5-trihydroxy-6-methyltetrahydro-
5,7-dihydroxy-3-
2-(3,4-dihydroxyphenyl)-
3-[(6-deoxy-a-l-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-benzopyran-4-one
BS-16996
quercitroside,(s)
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
Q1649777
CCG-269215
quercitrin (quercetin-3-o-rhamnoside) (constituent of ginkgo)
3-o-alpha-l-rhamnopyranosylquercetin
dtxcid50122721
3-((6-deoxy-alpha-l-mannopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-1-benzopyran-4-one

Research Excerpts

Overview

Quercitrin (Qc) is a well-known flavonoid compound that exerts anti-inflammation effects on various diseases. It is a natural compound found in Tartary buckwheat with a potential anti-inflammatory effect.

ExcerptReferenceRelevance
"Quercitrin (Qc) is a well-known flavonoid compound that exerts anti-inflammation effects on various diseases. "( Quercitrin Rapidly Alleviated Depression-like Behaviors in Lipopolysaccharide-Treated Mice: The Involvement of PI3K/AKT/NF-κB Signaling Suppression and CREB/BDNF Signaling Restoration in the Hippocampus.
Chen, G; Huang, J; Liu, T; Qian, S; Sun, Y; Wang, W; Wang, Z; Wu, Z; Xue, W; Yin, Y; Yu, X; Zhang, H, 2021
)
3.51
"Quercitrin is a naturally available type of flavonoid that commonly functions as the dietary ingredient and supplement. "( Chemistry, pharmacokinetics, pharmacological activities, and toxicity of Quercitrin.
Cao, X; Chen, J; Chen, Y; Li, G; Peng, C; Peng, F; Sun, C; Tan, Y; Tang, Y; Xie, X; Yu, L, 2022
)
2.4
"Quercitrin is a flavonoid that can efficiently improve both endocrine and metabolic abnormalities."( Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway.
Dang, H; Gao, S; Kang, M; Lan, P; Li, M; Wu, X; Yan, X; Zhang, X; Zheng, J, 2023
)
3.07
"Quercitrin is a natural compound found in Tartary buckwheat with a potential anti-inflammatory effect that is used to treat heart and vascular conditions."( Quercitrin ameliorates the development of systemic lupus erythematosus-like disease in a chronic graft-versus-host murine model.
Li, H; Li, W; Morel, L; Wang, M; Wei, Q; Wu, H; Yang, Y; Zhang, M; Zhong, Y, 2016
)
2.6
"Quercitrin is a flavonoid with antiinflammatory activity in experimental colitis, associated with an antioxidative action and amelioration of water absorption in vivo. "( Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat.
Gálvez, J; Sánchez de Medina, F; Vera, B; Zarzuelo, A, 2002
)
2.16

Treatment

Quercitrin treatment reversed the cytotoxic effect of H(2)O(2. Treatment also increased the expression of E-cadherin and PD98059 abrogated the upregulation of this protein.

ExcerptReferenceRelevance
"Quercitrin treatment also increased the expression of E-cadherin, and PD98059 abrogated the upregulation of E-cadherin induced by quercitrin."( Quercitrin treatment protects endothelial progenitor cells from oxidative damage via inducing autophagy through extracellular signal-regulated kinase.
Bai, J; Li, M; Qu, L; Wu, Y; Zhang, X; Zhi, K; Zhou, S, 2016
)
2.6
"Quercitrin treatment reversed the cytotoxic effect of H(2)O(2) significantly (P<0.05)."( Protective effect of quercitrin against hydrogen peroxide-induced dysfunction in osteoblastic MC3T3-E1 cells.
Choi, EM, 2012
)
1.42
"Quercitrin-treated rats had less diarrhoeal output and did not show mucosal hyperplasia after three days of treatment."( Effect of quercitrin on lactose-induced chronic diarrhoea in rats.
Fernández, MI; Gálvez, J; Gil, A; Jiménez, J; Núñez, MC; Ríos, A; Sánchez de Medina, F; Torres, MI; Zarzuelo, A, 1995
)
1.41
"Pretreatment of quercitrin increased collagen content, alkaline phosphatase (ALP) activity, and calcium deposition of osteoblasts compared with H(2)O(2) treated cells and these effects were blocked by ERKs and p38 mitogen-activated protein kinases (MAPKs) inhibitors such as PD98059 and SB203580, respectively."( Protective effect of quercitrin against hydrogen peroxide-induced dysfunction in osteoblastic MC3T3-E1 cells.
Choi, EM, 2012
)
1.03

Pharmacokinetics

The established method is specific,rapid,accurate and sensitive. It is proved to meet the requirements of biological sample analyses. The pharmacokinetic parameters suggested that quercitrin may be present in peripheral tissues of rats.

ExcerptReferenceRelevance
" The validated method was successfully applied to pharmacokinetic studies of the two analytes in rat plasma after the oral administration of Hypericum japonicum thunb."( HPLC analysis and pharmacokinetic study of quercitrin and isoquercitrin in rat plasma after administration of Hypericum japonicum thunb. extract.
Bi, KS; Chen, XH; Li, J; Liu, X; Wang, ZW; Zhang, L, 2008
)
0.61
"To develop a sensitive and reliable ultra performance liquid chromatography tandem mass spectrometry ( UPLC-MS / MS) method for simultaneous determination and pharmacokinetics of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, and study their pharmacokinetic characteristics in rats."( [Simultaneous Determination of Protocatechuic Acid,Kaempferol Biotin Glucoside and Quercitrin in Rat Plasma and Pharmacokinetics By UPLC-MS/MS].
Chen, SY; Li, YJ; Sun, J; Xiang, WY; Yang, W; Zheng, L, 2016
)
0.84
"The established method is specific,rapid,accurate and sensitive,and is proved to meet the requirements of biological sample analyses,and is suitable for the concentration determination of protocatechuic acid, kaempferol biotin glucoside and quercitrin in rat plasma, three compounds are all best fitted to the two-compartment open pharmacokinetic model."( [Simultaneous Determination of Protocatechuic Acid,Kaempferol Biotin Glucoside and Quercitrin in Rat Plasma and Pharmacokinetics By UPLC-MS/MS].
Chen, SY; Li, YJ; Sun, J; Xiang, WY; Yang, W; Zheng, L, 2016
)
0.84
"To develop and validate a sensitive and reliable ultra-high-performance liquid chromatography- tandem mass spectrometry (UHPLC-MS/MS) method for the quantitative determination of quercitrin levels in rat plasma, and test its application in a pharmacokinetic investigation after the oral administration of Polygoni cuspidati folium capsules (HC)."( Quantitative Determination of Quercitrin Levels in Rat Plasma Using UHPLC-MS/MS and its Application in a Pharmacokinetic Study after the Oral Administration of Polygoni cuspidati Folium Capsules.
Bi, XL; Feng, CT; Ma, ST; Zhang, N; Zhang, XY, 2022
)
1.2
" The pharmacokinetic parameters suggested that quercitrin may be present in the peripheral tissues of rats."( Quantitative Determination of Quercitrin Levels in Rat Plasma Using UHPLC-MS/MS and its Application in a Pharmacokinetic Study after the Oral Administration of Polygoni cuspidati Folium Capsules.
Bi, XL; Feng, CT; Ma, ST; Zhang, N; Zhang, XY, 2022
)
1.27

Bioavailability

ExcerptReferenceRelevance
" However, adequate intakes and absorption rate of phenolic compounds are necessary for these beneficial effects."( Influence of cooking process on phenolic marker compounds of vegetables.
Andlauer, W; Fürst, P; Hubert, M; Rings, A; Stumpf, C, 2003
)
0.32
" The poor bioavailability of important dietary quercetin glycosides has implications for their in vivo bioactivities."( The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides.
Arts, IC; Faassen-Peters, M; Hollman, PC; Sesink, AL, 2004
)
0.32
" Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy)."( Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Butterweck, V; Nahrstedt, A, 2010
)
0.36
" However, the generally low solubility, stability, bioavailability and target specificity, together with the side effects seen when used at high levels, have limited their application."( Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Moustaid-Moussa, N; Nie, S; Su, R; Sun, M; Wang, S; Wu, D; Zhang, J, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
"This paper describes a validated high-performance liquid chromatographic (HPLC) - photodiode array (PDA) detection method to quantitate five flavonol components as markers; rutin, quercitrin, quercetin, kaempferol and isorhamnetin for use in the quality control of Ginkgo biloba dosage forms."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.52
"A suitable method was developed to identify and quantitate five relevant flavonol marker compounds and was successfully used to assay some commercially available solid oral dosage forms of Ginkgo biloba ."( High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms.
Dubber, MJ; Kanfer, I, 2004
)
0.32
" The dose-response study showed that the IC50 values for ECG and Q3G on glucose uptake in BLMV were 294+/-89 microM and 357+/-52 microM, respectively."( Interaction of flavonoids and intestinal facilitated glucose transporters.
Chen, CH; Hsu, HJ; Huang, YJ; Lin, CJ, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
antileishmanial agentAn antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania.
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitorAn EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of carbonyl reductase (NADPH), EC 1.1.1.184.
EC 1.1.1.21 (aldehyde reductase) inhibitorAn EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD(+) or NADP(+) acceptor) inhibitor that interferes with the action of aldehyde reductase (EC 1.1.1.21).
EC 1.14.18.1 (tyrosinase) inhibitorAny EC 1.14.18.* (oxidoreductase acting on paired donors, miscellaneous compound as one donor, incorporating 1 atom of oxygen) inhibitor that interferes with the action of tyrosinase (monophenol monooxygenase), EC 1.14.18.1, an enzyme that catalyses the oxidation of phenols (such as tyrosine) and is widespread in plants and animals.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
tetrahydroxyflavoneAny hydroxyflavone carrying four hydroxy substituents.
alpha-L-rhamnoside
quercetin O-glycosideAny glycosyloxyflavone that is an O-glycosylated derivative of quercetin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Flavone and Flavonol Biosynthesis627
AtMetExpress overview0109

Protein Targets (30)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency28.18380.631035.7641100.0000AID504339
GLS proteinHomo sapiens (human)Potency35.48130.35487.935539.8107AID624170
importin subunit beta-1 isoform 1Homo sapiens (human)Potency50.11875.804836.130665.1308AID540263
flap endonuclease 1Homo sapiens (human)Potency39.81070.133725.412989.1251AID588795
snurportin-1Homo sapiens (human)Potency50.11875.804836.130665.1308AID540263
DNA polymerase eta isoform 1Homo sapiens (human)Potency39.81070.100028.9256213.3130AID588591
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency35.48130.050127.073689.1251AID588590
lethal(3)malignant brain tumor-like protein 1 isoform IHomo sapiens (human)Potency19.95260.075215.225339.8107AID485360
DNA polymerase kappa isoform 1Homo sapiens (human)Potency44.66840.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
integrase, partialHuman immunodeficiency virus 1IC50 (µMol)8.27200.07953.52039.9390AID1053171; AID1053172
lens epithelium-derived growth factor p75Homo sapiens (human)IC50 (µMol)8.27200.07953.52039.9390AID1053171; AID1053172
Polyphenol oxidase 2Agaricus bisporusIC50 (µMol)125.00000.03403.987110.0000AID1505136; AID1505139
Prostaglandin G/H synthase 1 Bos taurus (cattle)IC50 (µMol)2,000.00000.00051.41288.2000AID399401; AID399404; AID399405
Arginase Leishmania amazonensisIC50 (µMol)12.20001.60002.28004.0000AID1066694
Arginase Leishmania amazonensisKi7.90000.20002.12007.9000AID1066693
NeuraminidaseInfluenza A virus (A/USSR/90/1977(H1N1))IC50 (µMol)115.10000.00140.00550.0130AID1186763; AID1186764
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)IC50 (µMol)0.12000.00041.877310.0000AID34809; AID385353
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)1.07500.00101.191310.0000AID322413; AID639825
Aldo-keto reductase family 1 member B1Bos taurus (cattle)IC50 (µMol)10.00000.00702.589210.0000AID34503
Adenosine receptor A1Rattus norvegicus (Norway rat)IC50 (µMol)2,000.00000.00020.552110.0000AID399405
Adenosine receptor A2aRattus norvegicus (Norway rat)IC50 (µMol)2,000.00000.00120.48289.0000AID399405
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)11.80000.00000.54509.1000AID1712177
Bifunctional epoxide hydrolase 2Homo sapiens (human)Ki39.60000.00150.04540.1560AID1712179
Xanthine dehydrogenase/oxidaseHomo sapiens (human)IC50 (µMol)57.37000.00132.81389.8200AID336485; AID399340
Mitogen-activated protein kinase 10Homo sapiens (human)IC50 (µMol)24.15000.00201.703510.0000AID1799639
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)2,000.00000.00101.453910.0000AID399402; AID399405
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)24.15000.00010.72667.8000AID1799639
Aldo-keto reductase family 1 member C21Mus musculus (house mouse)IC50 (µMol)33.30006.90006.90006.9000AID322409
Serine/threonine-protein kinase pim-2Homo sapiens (human)IC50 (µMol)25.00000.00470.52145.1000AID327000
Non-structural protein 1 Dengue virusIC50 (µMol)1.70000.04101.32592.3000AID1599325
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prolyl 4-hydroxylase, beta polypeptideHomo sapiens (human)AC502.48000.015512.834845.2600AID602350; AID624274
glycogen synthase kinase-3 alphaHomo sapiens (human)AC5029.77000.013529.7434171.7000AID463203
Arginase Leishmania amazonensisKis7.20006.90007.05007.2000AID1066692
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (134)

Processvia Protein(s)Taxonomy
response to oxidative stressProstaglandin G/H synthase 1 Bos taurus (cattle)
cellular oxidant detoxificationProstaglandin G/H synthase 1 Bos taurus (cattle)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
retinol metabolic processAldo-keto reductase family 1 member B1Bos taurus (cattle)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
allantoin metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of protein phosphorylationXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell proliferationXanthine dehydrogenase/oxidaseHomo sapiens (human)
guanine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
inosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyinosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
adenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyadenosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
deoxyguanosine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
AMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
IMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
lactationXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of gene expressionXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron-sulfur cluster assemblyXanthine dehydrogenase/oxidaseHomo sapiens (human)
amide catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of endothelial cell differentiationXanthine dehydrogenase/oxidaseHomo sapiens (human)
GMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dGMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
dAMP catabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of p38MAPK cascadeXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayXanthine dehydrogenase/oxidaseHomo sapiens (human)
positive regulation of reactive oxygen species metabolic processXanthine dehydrogenase/oxidaseHomo sapiens (human)
negative regulation of vasculogenesisXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 10Homo sapiens (human)
signal transductionMitogen-activated protein kinase 10Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 10Homo sapiens (human)
response to light stimulusMitogen-activated protein kinase 10Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 10Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 10Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 10Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 10Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
G1/S transition of mitotic cell cycleSerine/threonine-protein kinase pim-2Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase pim-2Homo sapiens (human)
negative regulation of cell population proliferationSerine/threonine-protein kinase pim-2Homo sapiens (human)
apoptotic mitochondrial changesSerine/threonine-protein kinase pim-2Homo sapiens (human)
response to virusSerine/threonine-protein kinase pim-2Homo sapiens (human)
positive regulation of autophagySerine/threonine-protein kinase pim-2Homo sapiens (human)
macroautophagySerine/threonine-protein kinase pim-2Homo sapiens (human)
positive regulation of macroautophagySerine/threonine-protein kinase pim-2Homo sapiens (human)
negative regulation of apoptotic processSerine/threonine-protein kinase pim-2Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionSerine/threonine-protein kinase pim-2Homo sapiens (human)
positive regulation of DNA-templated transcriptionSerine/threonine-protein kinase pim-2Homo sapiens (human)
protein stabilizationSerine/threonine-protein kinase pim-2Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase pim-2Homo sapiens (human)
regulation of mitotic cell cycleSerine/threonine-protein kinase pim-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (41)

Processvia Protein(s)Taxonomy
peroxidase activityProstaglandin G/H synthase 1 Bos taurus (cattle)
heme bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
metal ion bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Bos taurus (cattle)
G protein-coupled adenosine receptor activityAdenosine receptor A2aRattus norvegicus (Norway rat)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
xanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
xanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
iron ion bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
protein homodimerization activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
molybdopterin cofactor bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
flavin adenine dinucleotide bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
2 iron, 2 sulfur cluster bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine dehydrogenase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
hypoxanthine oxidase activityXanthine dehydrogenase/oxidaseHomo sapiens (human)
FAD bindingXanthine dehydrogenase/oxidaseHomo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein bindingMitogen-activated protein kinase 10Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 10Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 10Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase pim-2Homo sapiens (human)
protein bindingSerine/threonine-protein kinase pim-2Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase pim-2Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase pim-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneProstaglandin G/H synthase 1 Bos taurus (cattle)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
Golgi membraneAdenosine receptor A2aRattus norvegicus (Norway rat)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
peroxisomeXanthine dehydrogenase/oxidaseHomo sapiens (human)
cytosolXanthine dehydrogenase/oxidaseHomo sapiens (human)
sarcoplasmic reticulumXanthine dehydrogenase/oxidaseHomo sapiens (human)
extracellular spaceXanthine dehydrogenase/oxidaseHomo sapiens (human)
nucleoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 10Homo sapiens (human)
plasma membraneMitogen-activated protein kinase 10Homo sapiens (human)
nucleusMitogen-activated protein kinase 10Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 10Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase pim-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (138)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1186767Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus (A/Perth/16/2009(H3N2))2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID639825Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Feb-01, Volume: 20, Issue:3
Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID385353Inhibition of rat lens aldose reductase2008Journal of natural products, Apr, Volume: 71, Issue:4
Erigeroflavanone, a flavanone derivative from the flowers of Erigeron annuus with protein glycation and aldose reductase inhibitory activity.
AID1064264Antiplatelet activity against New Zealand white rabbit platelets assessed as inhibition of ADP-induced platelet aggregation preincubated at 100 uM for 2 mins before challenge measured after 2 mins by spectrophotometry2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Lignans from the aerial parts of Saururus chinensis: isolation, structural characterization, and their effects on platelet aggregation.
AID399340Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID399301Inhibition of aldose reductase at 10 uM
AID379095Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 1 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379095Stimulation of BALB/c mouse cloned 3T3/A31 cells growth at 0.01 to 1 ug/mL1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID1064259Antiplatelet activity against New Zealand white rabbit platelets assessed as inhibition of PAF-induced platelet aggregation preincubated at 100 uM for 2 mins before challenge measured after 2 mins by spectrophotometry2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Lignans from the aerial parts of Saururus chinensis: isolation, structural characterization, and their effects on platelet aggregation.
AID492140Antioxidant activity assessed as formazan formation induced absorbance changes at 25 ppm at 570 nm at 37 degC for 6 hrs by MTT assay2010Journal of natural products, Jul-23, Volume: 73, Issue:7
An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds.
AID1066694Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
AID399405Inhibition of sheep placental cotyledons COX2 assessed as PGE2 production preincubated for 10 mins1998Journal of natural products, Jan, Volume: 61, Issue:1
Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
AID160029Antimalarial potency against Plasmodium falciparum at 0.5 ng/mL.2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
New anti-malarial flavonol glycoside from Hydrangeae Dulcis Folium.
AID1516847Antifungal activity against Candida parapsilosis 96 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID177556Ability to cause 50% reduction in sorbitol levels of sciatic nerve of streptozotocinized rats was determined1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Spiro hydantoin aldose reductase inhibitors.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID379093Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379093Growth inhibition of BALB/c mouse cloned 3T3/A31 cells at 100 ug/mL after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID1516857Antifungal activity against Candida glabrata 510 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID315607Growth inhibition of human BGC823 cells at 10 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID160028Anti-malarial potency against Plasmodium falciparum at 0.1 ng/ml2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
New anti-malarial flavonol glycoside from Hydrangeae Dulcis Folium.
AID403918Displacement of [3H]DPCPX from adenosine A1 receptor in rat forebrain membrane assessed as fraction of receptor bound radioligand at 100 ug/mL1997Journal of natural products, Jun, Volume: 60, Issue:6
Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis.
AID1505139Inhibition of mushroom tyrosinase2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID646459Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS/IFN-gamma-induced NO production at 25 to 100 uM after 20 hrs by Griess method2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Suppression of nitric oxide production on LPS/IFN-γ-stimulated RAW264.7 macrophages by a novel catechin, pilosanol N, from Agrimonia pilosa Ledeb.
AID34809In vitro inhibitory activity towards partially purified rat lens aldose reductase1988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Spiro hydantoin aldose reductase inhibitors.
AID1516858Antifungal activity against Candida glabrata 493 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID469284Cytotoxicity against african green monkey Vero cells after 3 days by MTT assay2009Journal of natural products, Sep, Volume: 72, Issue:9
Eucalmaidins A-E, (+)-oleuropeic acid derivatives from the fresh leaves of Eucalyptus maideni.
AID333526Cytotoxicity against human MCF7 cells at 20 mcg/mL after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID322409Inhibition of mouse recombinant AKR1C212008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
AID310105Antioxidant activity assessed as superoxide radical anion scavenging activity at 0.5 mg/ml by hypoxanthine NBT method2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
A novel flavonoid from Lespedeza virgata (Thunb.) DC.: structural elucidation and antioxidative activity.
AID160030Anti-malarial potency against Plasmodium falciparum at 5 ng/ml2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
New anti-malarial flavonol glycoside from Hydrangeae Dulcis Folium.
AID315606Growth inhibition of human BGC823 cells at 5 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1316658Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 1 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID332706Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID399341Antioxidant activity assessed as superoxide-scavenging activity by nitrite method1998Journal of natural products, Jan, Volume: 61, Issue:1
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
AID399404Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production preincubated for 10 mins1998Journal of natural products, Jan, Volume: 61, Issue:1
Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
AID1516859Antifungal activity against Candida glabrata 482 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID377040Hepatoprotective activity against H2O2-induced hepatotoxicity in Wistar rat hepatocytes assessed as reduction in glutamic pyruvate transaminase release after 1 hr relative to control2005Journal of natural products, Jan, Volume: 68, Issue:1
Two new hepatoprotective stilbene glycosides from Acer mono leaves.
AID336484ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity at 1 mM by spectrophotometry2002Journal of natural products, Nov, Volume: 65, Issue:11
Antioxidant and free-radical scavenging activity of constituents of the leaves of Tachigalia paniculata.
AID1186766Cytotoxicity against MDCK cells2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1186764Inhibition of influenza A virus (A/Perth/16/2009(H3N2)) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID362725Inhibition of Escherichia coli RNase H by FRET assay2008Journal of natural products, Sep, Volume: 71, Issue:9
HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1190384Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1599325Inhibition of dengue virus NS5 RNA dependent RNA polymerase2019European journal of medicinal chemistry, Aug-15, Volume: 176Recent update on anti-dengue drug discovery.
AID333523Cytotoxicity against human A549 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID1516855Antifungal activity against Candida glabrata 531 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1516850Antifungal activity against Candida albicans 501 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1316659Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1186763Inhibition of influenza A virus (A/California/07/2009(H1N1)) pdm09 neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID327000Inhibition of Pim2 kinase2008Journal of natural products, Mar, Volume: 71, Issue:3
Pim2 inhibitors from the Papua New Guinean plant Cupaniopsis macropetala.
AID478693Antidepressant activity in rat assessed as immobility time at 1.3 mg/kg, po by forced swimming test (Rvb = 150.3 +/- 11.1 sec)2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID1504884Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 at 40 uM after 72 hrs by DAPI staining based confocal microplate imaging method2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID1195523Inhibition of PTP1B (unknown origin) using pNPP substrate measured after 3 mins by colorimetric assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).
AID311863Inhibition of ICR mouse osteoclast differentiation at 1.0 ug/mL2007Journal of natural products, Dec, Volume: 70, Issue:12
Inhibitors of osteoclast differentiation from Cephalotaxus koreana.
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model
AID379089Growth inhibition of BALB/c mouse cloned 3T3/A31 cells after 72 hrs by nigrosin assay1999Journal of natural products, Mar, Volume: 62, Issue:3
Activities of plant-derived phenols in a fibroblast cell culture model.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID160027Antimalarial potency against Plasmodium falciparum at 0.05 ng/mL.2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
New anti-malarial flavonol glycoside from Hydrangeae Dulcis Folium.
AID1516848Antifungal activity against Candida tropicalis 166 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1505137Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins incubation under dark condition2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID1171178Cytotoxicity against human HCT116 cells at 1.25 to 20 uM after 96 hrs by MTT assay2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1516851Antifungal activity against Candida albicans 498 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID399299Inhibition of aldose reductase at 0.1 uM
AID1186044Cytotoxicity against human HL60 cells assessed as cell survival at 50 uM after 72 hrs by CCK8 assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
AID1064261Antiplatelet activity against New Zealand white rabbit platelets assessed as inhibition of arachidonic acid-induced platelet aggregation preincubated at 100 uM for 2 mins before challenge measured after 2 mins by spectrophotometry2014Journal of natural products, Jan-24, Volume: 77, Issue:1
Lignans from the aerial parts of Saururus chinensis: isolation, structural characterization, and their effects on platelet aggregation.
AID311862Inhibition of ICR mouse osteoclast differentiation at 0.1 ug/mL2007Journal of natural products, Dec, Volume: 70, Issue:12
Inhibitors of osteoclast differentiation from Cephalotaxus koreana.
AID1316661Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 100 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1504886Cytotoxicity against HEK293 cells at 40 uM after 72 hrs by resazurin dye based assay2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID1248399Inhibition of alpha-amylase (unknown origin) relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID1516856Antifungal activity against Candida glabrata 587 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID322413Inhibition of human recombinant aldose reductase2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
AID1239713Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition2015Bioorganic & medicinal chemistry letters, Aug-15, Volume: 25, Issue:16
Potential therapeutic agents for circulatory diseases from Bauhinia glauca Benth.subsp. pernervosa. (Da Ye Guan Men).
AID332708Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID355748Inhibition of Saccharomyces cerevisiae FAS2003Journal of natural products, Apr, Volume: 66, Issue:4
Phenolic compounds from Nymphaea odorata.
AID1171188Antitumor activity against human HCT116 cells xenografted in 48 hpf zebrafish embryo assessed as inhibition of cancer cell proliferation at 80 uM treated for 4 days2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Delineation of the role of glycosylation in the cytotoxic properties of quercetin using novel assays in living vertebrates.
AID1066692Noncompetitive inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate assessed as enzyme-substrate-inhibitor complex by Dixon reciprocal plot analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
AID1066693Noncompetitive inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate by Dixon reciprocal plot analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
AID333525Cytotoxicity against human A549 cells at 20 mcg/mL after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID1712176Inhibition of sEH (unknown origin) assessed as reduction in 6-methoxy-2-naphthaldehyde formation at 100 uM using PHOME as substrate measured after 40 mins by fluorescence photometry analysis relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Identification, characterization, kinetics, and molecular docking of flavonoid constituents from Archidendron clypearia (Jack.) Nielsen leaves and twigs.
AID1316657Antineuroinflammatory activity in human BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID1516852Antifungal activity against Candida albicans 53 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1431161Binding affinity to soybean p1 15-LOX at 10 ug after 1 hr by magnetic microbead affinity selection screening method2016Journal of natural products, 11-23, Volume: 79, Issue:11
Magnetic Microbead Affinity Selection Screening (MagMASS) of Botanical Extracts for Inhibitors of 15-Lipoxygenase.
AID1516849Antifungal activity against Candida krusei 168 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID399402Inhibition of sheep placental cotyledons COX2 assessed as PGE2 production1998Journal of natural products, Jan, Volume: 61, Issue:1
Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
AID1431159Inhibition of 15-LOX in soybean using linoleic acid as substrate measured for 30 to 90 secs2016Journal of natural products, 11-23, Volume: 79, Issue:11
Magnetic Microbead Affinity Selection Screening (MagMASS) of Botanical Extracts for Inhibitors of 15-Lipoxygenase.
AID315609Growth inhibition of human BGC823 cells at 100 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1190383Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID399401Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production1998Journal of natural products, Jan, Volume: 61, Issue:1
Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis.
AID95334Cytotoxic activity against KB 3-1 cells at 5 ug/mL.2001Bioorganic & medicinal chemistry letters, Sep-17, Volume: 11, Issue:18
New anti-malarial flavonol glycoside from Hydrangeae Dulcis Folium.
AID1316660Cytotoxicity against LPS-activated human BV2 cells assessed as cell viability at 30 uM after 24 hrs by MTT assay (Rvb = 98.03 to 98.84%)2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
Bioactive phenols as potential neuroinflammation inhibitors from the leaves of Xanthoceras sorbifolia Bunge.
AID399300Inhibition of aldose reductase at 1 uM
AID34503In vitro inhibition of partially purified calf lens aldose reductase; value ranges from 10E-5 to 10E-61988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Spiro hydantoin aldose reductase inhibitors.
AID1516853Antifungal activity against Candida albicans ATCC 10231 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1712177Inhibition of sEH (unknown origin) assessed as reduction in 6-methoxy-2-naphthaldehyde formation using PHOME as substrate measured after 40 mins by fluorescence photometry analysis2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Identification, characterization, kinetics, and molecular docking of flavonoid constituents from Archidendron clypearia (Jack.) Nielsen leaves and twigs.
AID399298Inhibition of aldose reductase at 0.01 uM
AID362726Inhibition of human RNase H by FRET assay2008Journal of natural products, Sep, Volume: 71, Issue:9
HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis.
AID1712179Non competitive inhibition of sEH (unknown origin) using varying levels of PHOME as substrate by Dixon plot analysis2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
Identification, characterization, kinetics, and molecular docking of flavonoid constituents from Archidendron clypearia (Jack.) Nielsen leaves and twigs.
AID1168660Antiviral activity against Dengue virus assessed as inhibition of viral replication2014European journal of medicinal chemistry, Nov-24, Volume: 87A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
AID1195522Inhibition of PTP1B (unknown origin) at 20 ug/ml using pNPP substrate measured after 3 mins by colorimetric assay2015Bioorganic & medicinal chemistry letters, , Volume: 25, Issue:10
PTP1B inhibitors from stems of Angelica keiskei (Ashitaba).
AID551196Inhibition of human HH/Gli1-mediated transcriptional activity in tetracycline-treated human HaCaT cells treated after 12 hrs of tetracycline addition by luciferase reporter gene assay2011Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2
New Hedgehog/GLI signaling inhibitors from Excoecaria agallocha.
AID315608Growth inhibition of human BGC823 cells at 50 uM after 72 hrs by MTT assay relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
Studies on the chemical constituents and anticancer activity of Saxifraga stolonifera (L) Meeb.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID336485Inhibition of xanthine oxidase-mediated formation of uric acid by spectrophotometry2002Journal of natural products, Nov, Volume: 65, Issue:11
Antioxidant and free-radical scavenging activity of constituents of the leaves of Tachigalia paniculata.
AID1190380Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1186765Inhibition of influenza B virus (B/Brisbane/60/2008) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase.
AID332704Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID362724Inhibition of HIV2 RNase H by FRET assay2008Journal of natural products, Sep, Volume: 71, Issue:9
HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis.
AID1190381Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot2015Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3
Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies.
AID1516854Antifungal activity against Candida glabrata 507 by microdilution method2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID469283Antiviral activity against HSV1 infected in african green monkey Vero cells assessed as inhibition of virus-induced cytopathic effect after 3 days by crystal violet staining2009Journal of natural products, Sep, Volume: 72, Issue:9
Eucalmaidins A-E, (+)-oleuropeic acid derivatives from the fresh leaves of Eucalyptus maideni.
AID399391Inhibition of HIV1 recombinant integrase expressed in Escherichia coli1998Journal of natural products, Jan, Volume: 61, Issue:1
A new flavonol glycoside gallate ester from Acer okamotoanum and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase.
AID1505136Inhibition of mushroom tyrosinase using L-tyrosine as substrate pretreated for 5 mins followed by substrate addition measured over 30 mins by spectrophotometric method2018Journal of natural products, 01-26, Volume: 81, Issue:1
Isolation of Flavonoids and Flavonoid Glycosides from Myrsine africana and Their Inhibitory Activities against Mushroom Tyrosinase.
AID1504882Growth inhibition of chloroquine-resistant Plasmodium falciparum Dd2 at 40 uM after 72 hrs by DAPI staining based confocal microplate imaging method relative to control2017Journal of natural products, 12-22, Volume: 80, Issue:12
Pimentelamines A-C, Indole Alkaloids Isolated from the Leaves of the Australian Tree Flindersia pimenteliana.
AID362723Inhibition of HIV1 RNase H by FRET assay2008Journal of natural products, Sep, Volume: 71, Issue:9
HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis.
AID333524Cytotoxicity against human MCF7 cells after 3 days by SRB assay2004Journal of natural products, Nov, Volume: 67, Issue:11
Prenylated benzophenones and xanthones from Hypericum scabrum.
AID478692Antidepressant activity in rat assessed as immobility time at 0.6 mg/kg, po by forced swimming test (Rvb = 150.3 +/- 11.1 sec)2010Journal of natural products, May-28, Volume: 73, Issue:5
Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
AID1186051Retention time of the compound by UPLC analysis2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
AID1799639Kinase Assay from Article 10.1002/cbic.201000487: \\Biological evaluation and structural determinants of p38u00CEu00B1 mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.\\2010Chembiochem : a European journal of chemical biology, Dec-10, Volume: 11, Issue:18
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2013Acta crystallographica. Section D, Biological crystallography, Feb, Volume: 69, Issue:Pt 2
Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (337)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (6.53)18.7374
1990's32 (9.50)18.2507
2000's95 (28.19)29.6817
2010's164 (48.66)24.3611
2020's24 (7.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.08 (24.57)
Research Supply Index5.86 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index69.65 (26.88)
Search Engine Supply Index2.97 (0.95)

This Compound (34.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (2.01%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other341 (97.99%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]